These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35719107)

  • 1. Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak.
    Kohn M; Alsuliman T; Lamure S; Cheminant M; Delage J; Merle De Boever C; Tudesq JJ; Marjanovic Z; Van de Wyngaert Z; Malard F; Brissot E; Rigaudeau S; Marque-Juillet S; Therby A; Cartron G; Rousselot P; Hermine O; Duléry R; Besson C
    Leuk Lymphoma; 2022 Nov; 63(11):2686-2690. PubMed ID: 35719107
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcomes in patients with chronic lymphocytic leukaemia infected during the omicron BA.5 subvariant surge.
    Bronstein Y; Levi S; Herishanu Y
    Br J Haematol; 2023 Jun; 201(6):1125-1128. PubMed ID: 37042235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir.
    Tadmor T; Melamed G; Patalon T; Alapi H; Rokach L
    Leuk Lymphoma; 2023 May; 64(5):1054-1056. PubMed ID: 36912366
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China.
    Zhu X; Jiang Q; Lu J; Sun Y; Zhao X; Yang S; Tang F; Yu W; Zhao T; Liu X; Jia J; Duan W; Hu L; Wang J; Liu Y; Peng N; Dou X; Ma R; Fu Q; Wang H; Liu K; Huang X; Jiang H
    Br J Haematol; 2023 Jul; 202(1):31-39. PubMed ID: 37092433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
    Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.
    Mayanskiy N; Luchkina P; Fedorova N; Lebedin Y; Ponomareva N
    Leukemia; 2021 Jun; 35(6):1820-1822. PubMed ID: 34007047
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia.
    Ingelman-Sundberg HM; Blixt L; Wullimann D; Wu J; Gao Y; Healy K; Muschiol S; Bogdanovic G; Åberg M; Kjellander C; Grifoni A; Sette A; Aleman S; Chen P; Blennow O; Hansson L; Ljunggren HG; Chen MS; Buggert M; Österborg A
    Haematologica; 2024 Feb; 109(2):646-651. PubMed ID: 37646668
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
    Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
    Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
    Smith-Jeffcoat SE; Pomeroy MA; Sleweon S; Sami S; Ricaldi JN; Gebru Y; Walker B; Brady S; Christenberry M; Bart S; Vostok J; Meyer S; Seys S; Markelz A; Ditto N; Newbern V; Thomas FJ; Thomas D; Cabredo E; Kellner S; Brown VR; Tate JE; Kirking HL
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):238-242. PubMed ID: 35176004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia.
    Mellinghoff SC; Mayer L; Robrecht S; Weskamm LM; Dahlke C; Gruell H; Schlotz M; Vanshylla K; Schloser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
    Haematologica; 2022 Oct; 107(10):2480-2484. PubMed ID: 35734927
    [No Abstract]   [Full Text] [Related]  

  • 11. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
    Charra B; Ellouadghiri A; Magramane A; Kebbou T; Damaan K; Maghfour A; Seddiki K; Ezzouine H
    Pan Afr Med J; 2020; 36():286. PubMed ID: 33117480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
    Guisado-Vasco P; Carralón-González MM; Aguareles-Gorines J; Martí-Ballesteros EM; Sánchez-Manzano MD; Carnevali-Ruiz D; García-Coca M; Barrena-Puertas R; de Viedma RG; Luque-Pinilla JM; Sotres-Fernandez G; Fernández-Sousa JM; Luepke-Estefan XE; López-Martín JA; Jimeno JM
    J Hematol Oncol; 2022 Jan; 15(1):4. PubMed ID: 35012608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.
    Langerbeins P; Fürstenau M; Gruell H; Klein F; Persigehl T; Rybniker J; Seeger-Nukpezah T; Kochanek M; Hallek M; Eichhorst B; Koehler P; Böll B
    Eur J Haematol; 2020 Oct; 105(4):508-511. PubMed ID: 32575156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.
    Kochneva ОL; Kislova M; Zhelnova EI; Petrenko AA; Baryakh EA; Yatskov KV; Dmitrieva EA; Misurina EN; Nikitin KE; Vasilieva EJ; Samsonova IV; Ptushkin VV; Baranova A; Nikitin EA
    Leuk Lymphoma; 2022 Jul; 63(7):1607-1616. PubMed ID: 35156528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistate Outbreak of Infection with SARS-CoV-2 Omicron Variant after Event in Chicago, Illinois, USA, 2021.
    Spencer H; Teran RA; Barbian HJ; Love S; Berg R; Black SR; Ghinai I; Kerins JL
    Emerg Infect Dis; 2022 Jun; 28(6):1281-1283. PubMed ID: 35608888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Omicron the last SARS-CoV-2 Variant of Concern?
    Rahimi F; Talebi Bezmin Abadi A
    Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report.
    Ali E; Badawi M; Abdelmahmuod E; Kohla S; Yassin MA
    Am J Case Rep; 2020 Oct; 21():e926062. PubMed ID: 33098641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children With Croup and SARS-CoV-2 Infection During the Large Outbreak of Omicron.
    Murata Y; Tomari K; Matsuoka T
    Pediatr Infect Dis J; 2022 May; 41(5):e249. PubMed ID: 35185142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.